These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 26806136

  • 1. Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C.
    Sagnelli C, Merli M, Uberti-Foppa C, Hasson H, Cirillo G, Grandone A, Salpietro S, Minichini C, Del Giudice EM, Lazzarin A, Sagnelli E, Coppola N.
    Clin Microbiol Infect; 2016 Apr; 22(4):372-378. PubMed ID: 26806136
    [Abstract] [Full Text] [Related]

  • 2. Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C.
    Zampino R, Coppola N, Cirillo G, Boemio A, Pisaturo M, Marrone A, Macera M, Sagnelli E, Perrone L, Adinolfi LE, Miraglia del Giudice E.
    J Viral Hepat; 2013 Aug; 20(8):517-23. PubMed ID: 23808989
    [Abstract] [Full Text] [Related]

  • 3. The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.
    Scheiner B, Mandorfer M, Schwabl P, Payer BA, Bucsics T, Bota S, Aichelburg MC, Grabmeier-Pfistershammer K, Stättermayer A, Ferenci P, Trauner M, Peck-Radosavljevic M, Reiberger T.
    PLoS One; 2015 Aug; 10(11):e0143429. PubMed ID: 26599080
    [Abstract] [Full Text] [Related]

  • 4. Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C.
    Yasui K, Kawaguchi T, Shima T, Mitsuyoshi H, Seki K, Sendo R, Mizuno M, Itoh Y, Matsuda F, Okanoue T.
    J Gastroenterol; 2015 Aug; 50(8):887-93. PubMed ID: 25543233
    [Abstract] [Full Text] [Related]

  • 5. TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.
    Sagnelli C, Merli M, Uberti-Foppa C, Hasson H, Grandone A, Cirillo G, Salpietro S, Minichini C, Starace M, Messina E, Morelli P, Miraglia Del Giudice E, Lazzarin A, Coppola N, Sagnelli E.
    World J Gastroenterol; 2016 Oct 14; 22(38):8509-8518. PubMed ID: 27784963
    [Abstract] [Full Text] [Related]

  • 6. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
    Manchiero C, Nunes AKDS, Magri MC, Dantas BP, Mazza CC, Barone AA, Tengan FM.
    BMC Infect Dis; 2017 Dec 19; 17(1):780. PubMed ID: 29258449
    [Abstract] [Full Text] [Related]

  • 7. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.
    Huang CF, Dai CY, Yeh ML, Huang CI, Tai CM, Hsieh MH, Liang PC, Lin YH, Hsieh MY, Yang HL, Huang JF, Lin ZY, Chen SC, Yu ML, Chuang WL.
    J Hepatol; 2015 Mar 19; 62(3):512-8. PubMed ID: 25457210
    [Abstract] [Full Text] [Related]

  • 8. Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients.
    Sagnelli C, Uberti-Foppa C, Hasson H, Bellini G, Minichini C, Salpietro S, Messina E, Barbanotti D, Merli M, Punzo F, Coppola N, Lazzarin A, Sagnelli E, Rossi F.
    PLoS One; 2017 Mar 19; 12(7):e0181890. PubMed ID: 28759568
    [Abstract] [Full Text] [Related]

  • 9. TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism.
    Coppola N, Rosa Z, Cirillo G, Stanzione M, Macera M, Boemio A, Grandone A, Pisaturo M, Marrone A, Adinolfi LE, Sagnelli E, Miraglia del Giudice E.
    Liver Int; 2015 Aug 19; 35(8):1959-63. PubMed ID: 25581573
    [Abstract] [Full Text] [Related]

  • 10. Association between PNPLA3[G]/I148M variant, steatosis and fibrosis stage in hepatitis C virus - genetic matters.
    Crisan D, Grigorescu M, Crisan N, Craciun R, Lupsor M, Radu C, Grigorescu MD, Suciu A, Epure F, Avram L, Leach N.
    J Physiol Pharmacol; 2019 Aug 19; 70(4):. PubMed ID: 31642820
    [Abstract] [Full Text] [Related]

  • 11. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.
    Valenti L, Rumi M, Galmozzi E, Aghemo A, Del Menico B, De Nicola S, Dongiovanni P, Maggioni M, Fracanzani AL, Rametta R, Colombo M, Fargion S.
    Hepatology; 2011 Mar 19; 53(3):791-9. PubMed ID: 21319195
    [Abstract] [Full Text] [Related]

  • 12. The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.
    Núñez-Torres R, Macías J, Mancebo M, Frías M, Dolci G, Téllez F, Merino D, Merchante N, Gómez-Mateos J, Guaraldi G, Rivero-Juárez A, Pineda JA, Real LM, HEPAVIR-esteatosis Study Group.
    PLoS One; 2016 Mar 19; 11(12):e0168265. PubMed ID: 27973562
    [Abstract] [Full Text] [Related]

  • 13. Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.
    Mandorfer M, Payer BA, Schwabl P, Steiner S, Ferlitsch A, Aichelburg MC, Stättermayer AF, Ferenci P, Obermayer-Pietsch B, Grabmeier-Pfistershammer K, Trauner M, Peck-Radosavljevic M, Reiberger T.
    Liver Int; 2015 Mar 19; 35(3):876-85. PubMed ID: 24905495
    [Abstract] [Full Text] [Related]

  • 14. TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C.
    Petta S, Maida M, Grimaudo S, Pipitone RM, Macaluso FS, Cabibi D, Cammà C, Di Marco V, Sferrazza S, Craxì A.
    Liver Int; 2016 Feb 19; 36(2):198-204. PubMed ID: 26259026
    [Abstract] [Full Text] [Related]

  • 15. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
    Valenti L, Maggioni P, Piperno A, Rametta R, Pelucchi S, Mariani R, Dongiovanni P, Fracanzani AL, Fargion S.
    World J Gastroenterol; 2012 Jun 14; 18(22):2813-20. PubMed ID: 22719190
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication.
    Chromy D, Mandorfer M, Bucsics T, Schwabl P, Bauer D, Scheiner B, Schmidbauer C, Lang GF, Szekeres T, Ferenci P, Trauner M, Reiberger T.
    AIDS Patient Care STDS; 2019 May 14; 33(5):197-206. PubMed ID: 31067123
    [Abstract] [Full Text] [Related]

  • 17. Impact of patatin-like phospholipase domain-containing 3 gene polymorphism (rs738409) on severity of liver disease in HIV/hepatitis C virus-coinfected patients.
    Jiménez-Sousa MA, Berenguer J, García-Álvarez M, Gutierrez-Rivas M, Aldámiz-Echevarria T, Tejerina F, Diez C, Vázquez-Morón S, Resino S.
    AIDS; 2016 Jan 28; 30(3):465-70. PubMed ID: 26760234
    [Abstract] [Full Text] [Related]

  • 18. Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C.
    De Nicola S, Dongiovanni P, Aghemo A, Cheroni C, D'Ambrosio R, Pedrazzini M, Marabita F, Donnici L, Maggioni M, Fargion S, Colombo M, De Francesco R, Valenti L.
    PLoS One; 2014 Jan 28; 9(8):e106022. PubMed ID: 25171251
    [Abstract] [Full Text] [Related]

  • 19. The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C.
    Oliveira AIN, Malta FM, Zitelli PMY, Salles APM, Gomes-Gouvea MS, Nastri ACS, Pinho JRR, Carrilho FJ, Oliveira CP, Mendes-Corrêa MC, Pessoa MG, Mazo DF.
    BMC Gastroenterol; 2021 Feb 23; 21(1):81. PubMed ID: 33622266
    [Abstract] [Full Text] [Related]

  • 20. Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B.
    Viganò M, Valenti L, Lampertico P, Facchetti F, Motta BM, D'Ambrosio R, Romagnoli S, Dongiovanni P, Donati B, Fargion S, Colombo M.
    Hepatology; 2013 Oct 23; 58(4):1245-52. PubMed ID: 23564580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.